LSEG Lipper’s John: Whither the small-cap premium?
Dewi John analyses the performance of small and mid caps across the UK US, and global equity markets over time
Dewi John analyses the performance of small and mid caps across the UK US, and global equity markets over time
|
|
Hundreds of billions have been pumped into AI, but when will it start producing profit, ask the Liontrust Global Innovation managers
|
|
Nvidia second quarter results post $30bn in revenue
|
|
Healthcare is an important allocation, but it has struggled to keep pace since covid – AI could fix that problem, says Caroline Langley
|
|
Strategies underexposed to tech and energy feature prominently in the bi-annual report
|
|
The recent run of weakness in the environmental sector presents a real opportunity for investors who believe in the long-term transition story
|
|
In his new monthly column, Ernst Knacke, head of research at Shard Capital, looks at the life sciences and biotech space
|
|
How CapEx from the Magnificent Seven is shaping markets
|
|
Stötzel talks tech, interest rates and innovation cycles
|
|
What does diversification mean during this period of mega-cap domination? Downing’s Alex Paget takes a look
|
|
Investors will benefit over the long-term by from diversifying their AI exposure, rather than piling into a single stock dominating headlines today, writes Brett Winton
|
|
Square Mile’s Ajay Vaid checks out the top performers and compelling newcomers
|
|